Výsledky vyhledávání - "Marlanka A Zuur"

Intermediate Susceptibility Dose-Dependent Breakpoints For High-Dose Rifampin, Isoniazid, and Pyrazinamide Treatment in Multidrug-Resistant Tuberculosis Programs

Autor: Tawanda Gumbo, Jotam G. Pasipanodya, Marlanka A Zuur, Dick van Soolingen, Jan-Willem C. Alffenaar, Tjip S. van der Werf

Publikováno v: Clinical Infectious Diseases, 67(11), 1743-1749. Oxford University Press
Clinical Infectious Diseases, 67, 1743-1749
Clinical Infectious Diseases, 67, 11, pp. 1743-1749

Background. Bacterial susceptibility is categorized as susceptible, intermediate-susceptible dose-dependent (ISDD), and resistant. The strategy is to use higher doses of first-line agents in the ISDD category, thereby preserving the use of these drug

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5a408be62db1f2c8d7b2605a24606cf9
https://doi.org/10.1093/cid/ciy346

Zobrazit plný text záznamu

Evaluation of Carbapenems for Treatment of Multi- and Extensively Drug-Resistant Mycobacterium tuberculosis

Autor: Richard van Altena, Jan-Willem C. Alffenaar, Tjip S. van der Werf, Onno W. Akkerman, Sander P. van Rijn, Richard M. Anthony, Jos G. W. Kosterink, Wiel C M de Lange, Marlanka A Zuur, Bob Wilffert

Publikováno v: Antimicrobial Agents and Chemotherapy, 63(2):ARTN e01489-18. AMER SOC MICROBIOLOGY

Multi-and extensively drug-resistant tuberculosis (M/XDR-TB) has become an increasing threat not only in countries where the TB burden is high but also in affluent regions, due to increased international travel and globalization. Carbapenems are earm

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::613ed5a2129cd1cad79f9cf2d79c5f6d
https://hdl.handle.net/11370/3cffdc31-fa1c-4706-8b1b-0df2bf3c86a7

Zobrazit plný text záznamu

Quality Assessment of Dried Blood Spots from Patients With Tuberculosis from 4 Countries

Autor: Nilza Martinez, Gladys Molinas, Golam Hasnain, Scott K. Heysell, Natascha van 't Boveneind-Vrubleuskaya, Daan J Touw, Andrej Tsivunchyk, Erwin M Jongedijk, Dinesh Mondal, Remco A. Koster, Alena Aleksa, Herman Veenhof, Cecile Magis-Escurra, Endang Darmawan, Marlanka A Zuur, Dyah Aryani Perwitasari, Ully Adhie Mulyani, Jan-Wilem C Alffenaar

Publikováno v: Therapeutic Drug Monitoring, 41, 6, pp. 714-718
Therapeutic Drug Monitoring, 41, 714-718

BACKGROUND: Dried blood spot (DBS) sampling is a blood collection tool that uses a finger prick to obtain a blood drop on a dried blood spot card. It can be used for therapeutic drug monitoring, a method that uses blood drug concentrations to optimiz

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6e51d6c484e38c1a7851140432edb826
https://hdl.handle.net/2066/215698

Zobrazit plný text záznamu

Evaluation of Carbapenems for Treatment of Multi- and Extensively Drug-Resistant

Autor: Sander P, van Rijn, Marlanka A, Zuur, Richard, Anthony, Bob, Wilffert, Richard, van Altena, Onno W, Akkerman, Wiel C M, de Lange, Tjip S, van der Werf, Jos G W, Kosterink, Jan-Willem C, Alffenaar

Publikováno v: Antimicrobial agents and chemotherapy. 63(2)

Multi- and extensively drug-resistant tuberculosis (M/XDR-TB) has become an increasing threat not only in countries where the TB burden is high but also in affluent regions, due to increased international travel and globalization. Carbapenems are ear

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::062fbde7ad52bed0e48bf9880bcf42ad
https://pubmed.ncbi.nlm.nih.gov/30455232

Zobrazit plný text záznamu

Pharmacokinetics of 2,000 Milligram Ertapenem in Tuberculosis Patients

Autor: Onno W. Akkerman, Marlanka A Zuur, T S van der Werf, W C M de Lange, Samiksha Ghimire, Mathieu S. Bolhuis, Daan J Touw, R. van Altena, Jos G. W. Kosterink, A. M. A. Wessels, Jan-Willem C. Alffenaar

Publikováno v: Antimicrobial Agents and Chemotherapy, 62(5):02250. AMER SOC MICROBIOLOGY

Ertapenem is a carbapenem antibiotic with activity against Mycobacterium tuberculosis . Dose simulations in a hollow-fiber infection model showed that 2,000 mg once daily is an appropriate dose to be tested in clinical studies. Before using this dose

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::615208f1986181d9b9dc07da36558f37
https://doi.org/10.1128/aac.02250-17

Zobrazit plný text záznamu

Pharmacokinetic Modeling and Limited Sampling Strategies Based on Healthy Volunteers for Monitoring of Ertapenem in Patients with Multidrug-Resistant Tuberculosis

Autor: Huib A. M. Kerstjens, Marlanka A Zuur, Jan-Willem C. Alffenaar, Jos G. W. Kosterink, Daan J Touw, Johannes H. Proost, R. van Altena, van Sander Rijn, de Wiel Lange, van der Tjipke Werf, Onno W. Akkerman

Publikováno v: Antimicrobial Agents and Chemotherapy, 61(4):UNSP e01783-16. AMER SOC MICROBIOLOGY

Ertapenem is a broad-spectrum carbapenem antibiotic whose activity against Mycobacterium tuberculosis is being explored. Carbapenems have antibacterial activity when the plasma concentration exceeds the MIC at least 40% of the time (40% T MIC ). To a

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4a317a089da465867b2adfb647163969
https://doi.org/10.1128/aac.01783-16

Zobrazit plný text záznamu

Fixed-dose combination and therapeutic drug monitoring in tuberculosis: friend or foe?

Autor: Marlanka A Zuur, Lina Davies Forsman, Onno W. Akkerman, Rongdong Zheng, Judith Bruchfeld, Yi Hu, Simon Tiberi, Giovanni Battista Migliori, Jan-Willem C. Alffenaar

Publikováno v: European Respiratory Journal, 48(4), 1230-1233. EUROPEAN RESPIRATORY SOC JOURNALS LTD

Fixed-dose combination and therapeutic drug monitoring can be combined in programmatic treatment of tuberculosis http://ow.ly/sCtd302h0Ka

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ece5290392b262bacbdd51e75df025b5
https://research.rug.nl/en/publications/1fed99c0-cb6c-4a3a-9adb-09204cfcbe22

Zobrazit plný text záznamu

Dried blood spots can help decrease the burden on patients dually infected with multidrug-resistant tuberculosis and HIV

Autor: Onno W. Akkerman, Tjip S. van der Werf, David M. Burger, Marlanka A Zuur, Jan-Willem C. Alffenaar, Daan J Touw, Frank Cobelens, Martin P. Grobusch

Publikováno v: European Respiratory Journal, 48(3), 932-934. EUROPEAN RESPIRATORY SOC JOURNALS LTD
European respiratory journal, 48(3), 932-934. European Respiratory Society

TDM with dried blood spots can simply and simultaneously monitor treatment in patients with MDR-TB with HIV http://ow.ly/TKIo300mwIY

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b8b23a73b66e3c0f363866b529e6d6bd
https://research.rug.nl/en/publications/75f96583-8a1c-41b9-a11a-9b7cd01d6fef

Zobrazit plný text záznamu

Current status and opportunities for therapeutic drug monitoring in the treatment of tuberculosis

Autor: Marlanka A Zuur, Alice L. den Hertog, Wiel C M de Lange, Tridia van der Laan, Dick van Soolingen, Jan-Willem C. Alffenaar, Richard M. Anthony, Mathieu S. Bolhuis, Bob Wilffert

Publikováno v: Expert Opinion on Drug Metabolism & Toxicology, 12, 5, pp. 509-21
Expert Opinion on Drug Metabolism & Toxicology, 12, 509-21

Introduction: Tuberculosis remains a global health problem and pharmacokinetic variability has been postulated as one of the causes of treatment failure and acquired drug resistance. New developments enable implementation of therapeutic drug monitori

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5efa8f2a04e8680f23fd1b8abba1b01e
https://doi.org/10.1517/17425255.2016.1162785

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání